Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Lakeland Financial Corp Discloses Q2 2026 Investor Presentation Materials

Lakeland Financial Corporation announced on July 27, 2026, that executive officers intend to use an investor presentation in meetings with institutional investors and analysts. The Indiana-based financial services company filed the presentation materials as part of its routine disclosure obligations, signaling management engagement with …

Aakashdeep | 27 July 2026

HBT Financial Raises Quarterly Dividend by 9 Percent as Company Announces Second Quarter 2026 Results

HBT Financial, Inc., a Bloomington, Illinois-based financial institution, announced on July 27, 2026 that its Board of Directors has increased the quarterly cash dividend by $0.02 per share to $0.25 per share, representing a 9 percent increase from the prior dividend level. The announcement …

Vinay Lochav | 27 July 2026

MapLight Therapeutics Discloses Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Acute Schizophrenia

MapLight Therapeutics, Inc. announced on July 27, 2026, the topline results from the ZEPHYR Phase 2 trial evaluating ML-007C-MA in inpatient adult participants with schizophrenia experiencing acute exacerbation of psychosis. The company disclosed the results through a conference call and accompanying presentation on the …

Aakashdeep | 27 July 2026

Neumora Therapeutics Reports Favorable Pre-Clinical Toxicology Results for NMRA-215 Candidate

Neumora Therapeutics, Inc. (NASDAQ: NMRA) announced favorable pre-clinical toxicology results from NMRA-215, its investigational therapeutic candidate, according to a disclosure filed on July 27, 2026. The announcement signals progress in the company's development pipeline and comes as the biopharmaceutical firm advances its clinical-stage programs. …

Shwetambri Chauhan | 27 July 2026

Ponce Financial Group Reports Second Quarter 2026 Results and Investor Presentation

Ponce Financial Group, Inc., the parent company of Ponce Bank, disclosed its financial results for the second quarter ended June 30, 2026, on July 27, 2026. The announcement included a press release outlining operational and financial performance metrics alongside a formal investor presentation. The …

Anjali Anand | 27 July 2026

Boost Run Inc. Initiates Warrant Redemption, Triggering $58.8 Million in Already-Exercised Warrants

Boost Run Inc. (NASDAQ: BRUN) announced on July 27, 2026, that it delivered a notice of redemption for all outstanding warrants on July 21, 2026, with a redemption deadline set for August 20, 2026. The company has already received $58.8 million in gross cash …

Anjali Anand | 27 July 2026

Precision BioSciences Promotes Chief Financial Officer to Chief Operating Officer, Appoints New CFO

Precision BioSciences, Inc. announced significant changes to its executive leadership team effective August 1, 2026. Alex Kelly, who has served as Chief Financial Officer since May 2021, was promoted to Chief Operating Officer with an increased annual base salary of $510,000. Naresh Tanna, who …

Vinay Lochav | 27 July 2026

Strive Inc. Purchases 79 Bitcoin as Holdings Expand to 20,000 BTC

Strive, Inc. announced on July 27, 2026, that it has acquired 79 bitcoin during the week of July 20–24, 2026, at an average price of approximately $65,723 per bitcoin inclusive of fees and expenses. The purchase brings the company's total bitcoin holdings to 20,000 …

Aakashdeep | 27 July 2026

Strategy Inc Completes Share Sales Under ATM Program While Executing Preferred Stock Repurchases

Strategy Inc (NASDAQ: MSTR) disclosed on July 27, 2026, that it sold 5.4 million shares of Class A common stock generating $544.5 million in net proceeds during the week of July 20-26, 2026. The company simultaneously repurchased 288,930 shares of Variable Rate Series A …

Anjali Anand | 27 July 2026

Kyverna Therapeutics Establishes Five-Year Clinical and Commercial Supply Agreement with ElevateBio for miv-cel Manufacturing

Kyverna Therapeutics, Inc. has entered into a new Clinical and Commercial Supply Agreement with ElevateBio Basecamp, Inc. effective July 23, 2026, replacing a prior development and manufacturing services arrangement. The agreement establishes a structured framework for the production and supply of mivocabtagene autoleucel (miv-cel), …

Anjali Anand | 27 July 2026
Support

Hi! How can we help you today?

Loading…